NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

This is one of a few times I have actually replied to you; most time I simply ignore you for obvious reason.

The reason for the last publication to take considerate long time is because the content of that publication is blended, blinded trial data. As you said at the time, no Journals would publish such a crabshoot;

Now the content of the to be published trial data is unblinded data of an unprecedented 14 years long, data rich pivotal phase 3 DCVax-L for one of the deadest cancers. I can tell you there will be fierce competition for the right to publish such data, and time is short.

There are a couple of prestigious Journals now regrets to the core for refusing to publish the blinded data last time, only seeing it was published in Journal of Translational Medicine with huge success, with many tens of thousands of accesses, and significant numbers of citation.

They will not hesitate this time.

I know you know all the above, and I am just waste my time for you, but once in a while I just cannot help...